°Ë»ö
ä¿ë
Á¤º¸
    "³²¼ºÈ£¸£¸ó ºÎÁ·ÇÏ¸é ¾ËÂêÇÏÀÌ¸Ó À§Çè"
    ±â»çÀÔ·Â : 04.01.29 21:15:36
    0 °¡
    ÇÃÄ£Ãß°¡
    ¹Ì±¹ ±¹¸³³ëÈ­¿¬±¸¼Ò, 549¸í ÃßÀû°á°ú ¹ßº´¿©ºÎ È®¿¬



    ³²¼ºÈ£¸£¸ó Å×½ºÅ佺Å×·ÐÀÌ ºÎÁ·ÇÏ¸é ¾ËÃ÷ÇÏÀ̸Ӻ´ À§ÇèÀÌ ³ô¾ÆÁø´Ù´Â ¿¬±¸°á°ú°¡ ³ª¿Ô´Ù.

    ¹Ì±¹ ±¹¸³³ëÈ­¿¬±¸¼Ò(NIA) ¼öÀü ·¹½º´Ð ¹Ú»ç´Â '½Å°æÀÇÇÐ' ÃÖ½ÅÈ£¿¡ ¹ßÇ¥ÇÑ º¸°í¼­¿¡¼­ À̰°ÀÌ ÁÖÀåÇß´Ù.

    ¼öÀü ¹Ú»ç´Â ³²ÀÚ 549¸í¸¦ 19³âµ¿¾È ÃßÀûÇϸ鼭 Áß°£Áß°£ Ç÷Áß Å×½ºÆ®·Î½ºÅ×·Ð ¼öÄ¡¸¦ °Ë»çÇÏ°í ¾ËÃ÷ÇÏÀ̸Ӻ´ ¹ßº´¿©ºÎ¸¦ Á¶»çÇß´Ù.

    ÀÌ ¿¬±¸¿¡¼­ 54¸íÀÌ ¾ËÃ÷ÇÏÀ̸Ӻ´¿¡ °É·Á ´Ù¸¥ ´Ü¹éÁúµé°ú °áÇÕÇÏ°í ³²Àº À¯¸®Çü(free) Å×½ºÅ佺Å×·ÐÀÇ Ç÷Áß ¼öÄ¡°¡ ³·À»¼ö·Ï ¾ËÃ÷ÇÏÀ̸Ӻ´ ¹ßº´·üÀÌ ³ô°í ¼öÄ¡°¡ ³ôÀ»¼ö·Ï ¹ßº´·üÀÌ ³·¾Ò´Ù°í ¸»Çß´Ù.
    X
    AD
    2025 µÑÄÚ¶ô½º ½ÉÆ÷Áö¾ö REPLAY À̺¥Æ®Âü¿© ¡æ
    Á¤½Ã¿í ±âÀÚ(sujung@dailypharm.com)
    ±ÛÀÚÅ©±â ¼³Á¤
    °¡³ª´Ù¶ó¸¶¹Ù»ç
    °¡³ª´Ù¶ó¸¶¹Ù»ç
    °¡³ª´Ù¶ó¸¶¹Ù»ç
    • 2025³â »ó¹Ý±â ¼ö½Ãä¿ë(ÇмúÀÇÇнÇ, BDÆÀ ¾à»ç) ¹Ù·Î°¡±â
    • º»»ç Medical Affairs ä¿ë ¹Ù·Î°¡±â
    • º»»ç ½ÅÀÔ RA ¾à»ç ä¿ë ¹Ù·Î°¡±â
    • RA, PMS, MSL ,PM, MR, MM µî °¢ ºÎ¹® ¸ðÁý ¹Ù·Î°¡±â
    • [Çѵ¶] Çѵ¶ÇコÄÉ¾î °æ¿µ°ü¸®, MA, Ãѹ« ÆÀÀå, Á¦Á¶°ü¸® ¾à»ç, ÀÌÈ­ÇнÃÇè(QC), ±â¼úÆÀ ±³Á¤´ã´ç, Àü¹®ÀǾàǰ ¸¶ÄÉÆÃ, ÀϹÝÀǾàǰ ¸¶ÄÉÆÃ ¹Ù·Î°¡±â
    • ÃæºÏ À½¼º Á¦Á¶°ü¸®¾à»ç ä¿ë ¹Ù·Î°¡±â
    • [Á¦¾à»ç¾÷ºÎ¹®] °³¹ßÆÀ(RA) ¾à»ç ½ÅÀÔ/°æ·Â ä¿ë ¹Ù·Î°¡±â
    • °æ·ÂÁ÷ MRä¿ë (¼öµµ±Ç) ¹Ù·Î°¡±â
    • R&D¼¾ÅÍ ¿¬±¸¿ø ½ÅÀÔ/°æ·Â ä¿ë ¹Ù·Î°¡±â
    • Senior Associate, PV (Pharmacovigilance) ¹Ù·Î°¡±â
    • Sr. RA Specialist & RA Specialist (2 Year Contract) ¹Ù·Î°¡±â
    • °­¸ª°øÀå Á¦Á¶°ü¸®¾à»ç °æ·Â¹«°ü ¹Ù·Î°¡±â
    0/300
     
    ¸ÞÀϺ¸³»±â
    ±â»çÁ¦¸ñ : ³²¼ºÈ£¸£¸ó ºÎÁ·ÇÏ¸é ¾ËÂêÇÏÀÌ¸Ó À§Çè